Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Elanco Tiergesundheit AG seeks a Senior Research Scientist in Analytical Development to lead dissolution and analytic method development for animal health products. You will work within the TD organization to support drug development and regulatory submissions, ensuring adherence to GxP.
Ideal candidates have a PhD with 5+ years in pharma development and strong skills in HPLC/UPLC, UV/VIS, and dissolution, with experience engaging with regulatory agencies such as FDA/EMA.
At Elanco (NYSE: ELAN) – it all starts with animals! As a global leader in animal health, we are dedicated to innovation and delivering products and services to prevent and treat disease in farm animals and pets. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our purpose – all to Go Beyond for Animals, Customers, Society and Our People. At Elanco, we pride ourselves on fostering a diverse and inclusive work environment. We believe that diversity is the driving force behind innovation, creativity, and overall business success. Here, you’ll be part of a company that values and champions new ways of thinking, work with dynamic individuals, and acquire new skills and experiences that will propel your career to new heights. Making animals’ lives better makes life better – join our team today!
As the Senior Research Scientist - Analytical Development, you will support Elanco’s Technical Development (TD) organization. This position is broadly responsible for analytical development activities of animal health products with a concentrated focus in dissolution control strategy and synthetic molecule analytical development. As part of technical development teams, the role is expected to support drug development with a diverse range of responsibilities.
Travel: Approximately 10% travel required.
Monheim, Germany
Elanco is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose CSR framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.